Drug Channels Institute

Drug Channels Institute (DCI) is described on its official site as a leading source of industry research about pharmaceutical economics and the drug distribution system, and as a leading provider of specialized management education for and about the pharmaceutical industry. It is a subsidiary of HMP Global. DCI publishes industry reports, including the Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers and the Economic Report on Pharmaceutical Wholesalers and Specialty Distributors, and operates the Drug Channels website (DrugChannels.net), which it says has been helping readers make sense of pharmaceutical economics since 2006 and reaches an audience of more than 100,000 professionals.

Drug Channels Institute operates the Drug Channels website, which it says has been helping thousands of readers make sense of pharmaceutical economics and the drug distribution system since 2006. The site delivers weekly analysis and opinions on topics such as pharmacy economics and prescription profits, pharmaceutical reimbursement, business strategies of key market participants including manufacturers, pharmacies, pharmacy benefit managers (PBMs), third-party payers, and wholesalers, industry evolution and trends, the specialty drug market, health care reform and policy, and legal aspects of the pharmaceutical supply chain. Drug Channels Institute is a subsidiary of HMP Global. It publishes industry reports, including the 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers and the 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors, the latter announced for release on October 12, 2026.

A leading source of industry research about pharmaceutical economics and the drug distribution system; a leading provider of specialized management education for and about the pharmaceutical industry.

• The 2026 Economic Report on U.S. Pharmacies and Pharmacy Benefit Managers

  Described by DCI as the ultimate guide to the complex web of interactions within the U.S. prescription distribution and reimbursement system.

• The 2026-27 Economic Report on Pharmaceutical Wholesalers and Specialty Distributors

  Described by DCI as the most comprehensive tool for analyzing the economic and business realities of the U.S. pharmaceutical distribution industry; announced for release on October 12, 2026.

• Drug Channels Website (DrugChannels.net)

  An online publication on pharmaceutical economics that since 2006 has delivered weekly analysis and opinions on pharmaceutical economics and the drug distribution system.

1. 1Drug Channels Institutedrugchannelsinstitute.com
2. 2Drug Channels Institute | About Usdrugchannelsinstitute.com
3. 3Drug Channels Institute | Drug Channels Websitedrugchannelsinstitute.com
4. 4Drug Channels Institutewikidata.org